Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
HIV vaccine development
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Classification of possible vaccines== Theoretically, any possible HIV vaccine must inhibit or stop the HIV virion replication cycle.<ref>{{cite book | last1 = Collier | first1 = Leslie | last2 = Balows | first2 = Albert | last3 = Sussman | first3 = Max | date = 1998 | series = Topley and Wilson's Microbiology and Microbial Infections | edition = ninth | volume = 1 | title = Virology | editor1-last = Mahy | editor1-first = Brian | editor2-last = Collier | editor2-first = Leslie | name-list-style = vanc | publisher = Hodder Education Publishers | isbn = 978-0-340-66316-5 | pages = 75β91 }}</ref> The targets of a vaccine could be the following stages of the HIV virion cycle: * Stage I. Free state * Stage II. Attachment * Stage III. Penetration * Stage IV. Uncoating * Stage V. Replication * Stage VI. Assembling * Stage VII. Releasing Therefore, the following list comprises the current possible approaches for an HIV vaccine: ===Filtering virions from blood (Stage I)=== * Biological, chemical and/or physical approaches for removing the HIV virions from the blood. ===Approaches to catching the virion (Stage I-III, VI, VII)=== * [[Phagocytosis]] of the HIV virions. * Chemical or organically based capture (creation of any skin or additional membrane around the virion) of HIV virions * Chemical or organic attachments to the virion ===Approaches to destroying or damaging the virion or its parts (Stage I-VII)=== Here, "damage" means inhibiting or stopping the ability of virion to process any of the ''Phase II-VII''. Here are the different classification of methods: * By nature of method: ** Physical methods (''Stage I-VII'') ** Chemical and biological methods (''Stage I-VII'') * By damaging target of the [[HIV#Structure and genome|HIV virion structure]]:<ref>{{cite journal | vauthors = McGovern SL, Caselli E, Grigorieff N, Shoichet BK | title = A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening | journal = Journal of Medicinal Chemistry | volume = 45 | issue = 8 | pages = 1712β22 | date = April 2002 | pmid = 11931626 | doi = 10.1021/jm010533y }}</ref><ref>Compared with overview in: Fisher, Bruce; Harvey, Richard P.; Champe, Pamela C. (2007). Lippincott's Illustrated Reviews: Microbiology (Lippincott's Illustrated Reviews Series). Hagerstown, MD: Lippincott Williams & Wilkins. {{ISBN|0-7817-8215-5}}. Page 3</ref> ** Damaging the [[Envelope glycoprotein GP120|Docking Glycoprotein gp120]]<ref>{{cite report | title = HIV Sequence Compendium | year = 2017 | vauthors = Foley B, Leitner T, Apetrei C, Hahn B, Mizrachi I, Mullins J, Rambaut A, Wolinsky S, Korber B | publisher = Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, NM, LA-UR 17-25240 }}</ref> (''Stage I-III, VI, VII'') ** Damaging the [[Gp41|Transmembrane Glycoprotein gp41]]<ref>{{cite journal | vauthors = Malashkevich VN, Chan DC, Chutkowski CT, Kim PS | title = Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 95 | issue = 16 | pages = 9134β9 | date = August 1998 | pmid = 9689046 | pmc = 21304 | doi = 10.1073/pnas.95.16.9134 | bibcode = 1998PNAS...95.9134M | doi-access = free }}</ref> (''Stage I-III, VI, VII'') ** Damaging the virion matrix (''Stage I-III, VI, VII'') ** Damaging the virion Capsid (''Stage I-III, VI, VII'') ** Damaging the Reverse Transcriptase (''Stage I-VII'') ** Damaging the RNA (''Stage I-VII'') ===Blocking replication (Stage V)=== * Insertion into blood chemical or organic compounds which binds to the [[gp120]]. Hypothetically, it can be pieces of the [[CD4]] cell membranes with receptors. Any chemical and organic alternative (with the ability to bind the gp120) of these receptors also can be used. * Insertion into blood chemical or organic compounds which binds to the receptors of the CD4 cells. ===Biological, chemical or physical approaches to inhibit the process of phases=== * Biological, chemical or physical approach to inhibit the ''Attachment, Penetration, Uncoating, Integration, Replication, Assembling and/or Releasing.'' ===Inhibiting the functionality of infected cells (Stage VI-VII)=== Inhibiting the life functions of infected cells: * Inhibiting the metabolism of infected cells * Inhibiting the energy exchange of infected cells
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)